Compendia Bioscience

Ann Arbor, United States Founded: 2006 • Age: 20 yrs Acquired By Life Technologies
Genomic data and tools are offered for oncology biomarker discoveries.
Request Access

About Compendia Bioscience

Compendia Bioscience was founded in 2006 in Ann Arbor, United States, within the bioscience sector. Genomic data and analysis tools are provided for biomarker and gene target identification, primarily in oncology. Operations include web applications such as Oncomine editions for cancer profiling, OncoScore for patient stratification in clinical trials, OncoPredictor tools for biomarker evaluation across preclinical and clinical populations, and solutions for target validation through genomic aberrations and expression analysis.

  • Headquarter Ann Arbor, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $2.4 M (USD), Grant

    Oct 11, 2007

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Life Technologies

    (Oct 08, 2012)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Compendia Bioscience

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $2.4M
  • First Round

    (11 Oct 2007)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2007 Amount Grant - Compendia Bioscience Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Compendia Bioscience

Compendia Bioscience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Life Technologies and NIH SBIR/STTR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Tools and technologies for biotech and biopharma research were supplied.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Compendia Bioscience

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Compendia Bioscience

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Compendia Bioscience Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Compendia Bioscience

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Compendia Bioscience

Frequently Asked Questions about Compendia Bioscience

When was Compendia Bioscience founded?

Compendia Bioscience was founded in 2006 and raised its 1st funding round 1 year after it was founded.

Where is Compendia Bioscience located?

Compendia Bioscience is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.

What does Compendia Bioscience do?

Compendia Bioscience was founded in 2006 in Ann Arbor, United States, within the bioscience sector. Genomic data and analysis tools are provided for biomarker and gene target identification, primarily in oncology. Operations include web applications such as Oncomine editions for cancer profiling, OncoScore for patient stratification in clinical trials, OncoPredictor tools for biomarker evaluation across preclinical and clinical populations, and solutions for target validation through genomic aberrations and expression analysis.

Who are Compendia Bioscience's investors?

Compendia Bioscience has 2 investors. Key investors include Life Technologies, and NIH SBIR/STTR.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available